Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trial (Q34720308)

4 August 2017

title

Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trial (English)

1 reference

4 August 2017

main subject

phase I clinical trial

0 references

immunization

0 references

metastatic breast cancer

1 reference

L Norton

13

0 references

Katherine S Panageas

10

object named as

K S Panageas

1 reference

4 August 2017

T Gilewski

1

1 reference

4 August 2017

G Ragupathi

2

1 reference

4 August 2017

S Bhuta

3

1 reference

4 August 2017

L J Williams

4

1 reference

4 August 2017

C Musselli

5

1 reference

4 August 2017

X F Zhang

6

1 reference

4 August 2017

W G Bornmann

7

1 reference

4 August 2017

M Spassova

8

1 reference

4 August 2017

K P Bencsath

9

1 reference

4 August 2017

J Chin

11

1 reference

4 August 2017

C A Hudis

12

1 reference

4 August 2017

A N Houghton

14

1 reference

4 August 2017

P O Livingston

15

1 reference

4 August 2017

S J Danishefsky

16

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

Proceedings of the National Academy of Sciences of the United States of America

4 August 2017

published in

1 reference

4 August 2017

volume

98

1 reference

4 August 2017

issue

6

1 reference

4 August 2017

page(s)

3270-3275

1 reference

Development of a new vaccine formulation that enhances the immunogenicity of tumor-associated antigen CaMBr1.

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30643

Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30643

Polyclonal antibodies from patients immunized with a globo H-keyhole limpet hemocyanin vaccine: isolation, quantification, and characterization of immune responses by using totally synthetic immobilized tumor antigens

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30643

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30643

Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30643

Carbohydrate vaccines that induce antibodies against cancer. 2. Previous experience and future plans

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30643

Carbohydrate vaccines that induce antibodies against cancer. 1. Rationale

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30643

Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30643

Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30643

Antibodies against autologous tumor cell proteins in patients with small-cell lung cancer: association with improved survival

7 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073/PNAS.051626298

Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073/PNAS.051626298

Optimal sample size for a series of pilot trials of new agents

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073/PNAS.051626298

Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30643

Generation of monoclonal antibodies reacting with normal and cancer cells of human breast

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30643

Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex

26 October 2018

1 reference

12 December 2020

A Fully Synthetic Globo H Carbohydrate Vaccine Induces a Focused Humoral Response in Prostate Cancer Patients: A Proof of Principle

1 reference

12 December 2020

Characterization of a glycosphingolipid antigen defined by the monoclonal antibody MBr1 expressed in normal and neoplastic epithelial cells of human mammary gland

1 reference

12 December 2020

Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen

1 reference

12 December 2020

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside

1 reference

12 December 2020

GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines

1 reference

12 December 2020

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

1 reference

12 December 2020

Pre-immunotherapy serum CA27.29 (MUC-1) mucin level and CD69 lymphocytes correlate with effects of Theratope sialyl-Tn-KLH cancer vaccine in active specific immunotherapy

1 reference

12 December 2020

Augmenting the immunogenicity of synthetic MUC1 peptide vaccines in mice

1 reference

12 December 2020

Tumor cell reactivity mediated by IgM antibodies in sera from melanoma patients vaccinated with GM2 ganglioside covalently linked to KLH is increased by IgG antibodies

1 reference

12 December 2020

A novel and efficient method for synthetic carbohydrate conjugate vaccine preparation: synthesis of sialyl Tn-KLH conjugate using a 4-(4-N-maleimidomethyl) cyclohexane-1-carboxyl hydrazide (MMCCH) linker arm

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.051626298

1 reference

4 August 2017

0 references

1 reference

4 August 2017

1 reference